Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement
暂无分享,去创建一个
U. Christians | Chris Nakas | A. Leichtle | C. Largiadèr | P. Mohacsi | L. Englberger | J. Sistonen | V. Sigurdardottir | M. Fiedler | Dorothea Lesche